Xianju Pharmaceutical: Announcement on the progress of the public listing and transfer of 61.2% of the shares of the holding subsidiary Haisheng Pharmaceutical

SZSI · Apr 19, 2022 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.